Cystatin C (Immunofluorescence Chromatography) (CysC) Clinical Comparison In ICU

CysC overview

Cysteinase proteinase inhibitor (CPI) was named cystatin C. Circulation of Cystatin C can only be removed by glomerular filtration (an endogenous marker that reflects changes in the glomerular filtration rate) and reabsorbed by the urethral duct near the stomach curve, but is then completely metabolized and broken down. It's not reabsorbed, it doesn't go back into the bloodstream. Therefore, the concentration of cysteine C in blood is determined by the glomerular filtration rate and is an ideal endogenous marker to reflect the change of glomerular filtration rate independent of external factors such as gender, age and diet.

CysC performance index

Clinical significance of CysC

• It is the ideal endogenous marker of GFR response
• Renal function assessment in high-risk groups for AKI
• Detection of renal function during chronic disease management

Sensitivity comparison of cystatin C and serum creatinine in the evaluation of GFR

Application Department

Internal medicine, pediatrics, orthopedics, cardiology, emergency, ICU, Nephrology, oncology, surgery, etc

Clinical comparison of CysC

Company profile

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purification workshop of national standards, and a fully functional inspection center. On this basis, the company will continue to invest in research and development, accumulate technical strength, update manufacturing equipment, improve production technology, improve inspection technology, improve product quality, and provide customers with safe and effective in vitro diagnostic products.

Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, immune series, microbial series and other reagents and supporting instruments.

The company has always adhered to the core concept of “fast and accurate, living up to life”, committed to providing society with excellent products and services, and contributing to the cause of human health.